IP Library › Granted Patent US 10,292,955
Granted Patent B2
US 10,292,955 · App. 14/779,927 · Granted May 21, 2019

Composition for external use preparation with improved transdermal permeability

Inventors: Dong il Lee (Gyeonggi-do, KR); Min ji Yoon (Seoul, KR); Pung Sok Lee (Gyeonggi-do, KR)
Assignee: HYUNDAI PHARM CO., LTD.
A61K31/195A61K8/44A61K9/0014A61K9/06A61K47/08A61K47/10A61K47/14A61K47/26A61Q19/00A61Q19/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,292,955
App. No.
14/779,927
Granted
May 21, 2019
Kind
B2
Abstract

Provided is a skin external composition, which includes tranexamic acid or a salt thereof and a skin penetration enhancer, thereby showing remarkably increased skin permeability and improved sense of use, skin irritation, and storage stability.

Claims (17)

1. A method for enhancing skin permeability of tranexamic acid or a salt thereof, comprising the step of applying a skin external composition in the form of a soluble system or an emulsion system consisting of:

(i) tranexamic acid or a salt thereof, and

(ii) a skin penetration enhancer, which is a combination of (a) a material selected from the group consisting of sorbitol, isopropyl myristate, and propylene glycol monolaurate, and (b) diethylene glycol monoethyl ether,

(iii) additives,

(iv) a surfactant in an amount of 1 to 10% by weight,

(v) a thickener in an amount of 0.01 to 3% by weight,

(vi) a pH adjusting agent in an amount of 0.01 to 2% by weight, and

wherein the skin permeability of tranexamic acid or a salt thereof is 10% to 100% after the composition is applied to a skin for 24 hours.

2. The method of claim 1 , wherein the composition comprises tranexamic acid or the salt thereof in an amount of 0.01 to 10% by weight.

3. The method of claim 1 , wherein the composition comprises the skin penetration enhancer in an amount of 1 to 10% by weight.

4. The method of claim 1 , wherein the surfactant is an anionic surfactant, a cationic surfactant, or an amphoteric surfactant.

5. The method of claim 1 , wherein the thickener is selected from the group consisting of hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxyvinyl polymer, alkyl modified carboxyvinyl polymer, polyacrylamide, sodium alginate, propylene glycol alginate, agar, sodium polyacrylate, succinoglucan, dextran, mannan, marmelo, algae colloid, pectin, gellan gum, carrageenan, hyaluronic acid, polyvinyl alcohol, high polymerization degree polyethylene glycol, bentonite, magnesium aluminum silicate, Laponite, hectorite, and silicic anhydride.

6. The method of claim 1 , wherein the pH adjusting agent is selected from the group consisting of sodium hydroxide, boric acid, citric acid, alkanolamide, triethanolamine, acetic acid, sodium hydrogen carbonate, phosphoric acid, ammonia water, sodium sulfite, sodium hexametaphosphate, glucono-delta-lactone, adipic acid, and tetrasodium phosphate.

7. The method of claim 1 , wherein skin permeability of tranexamic acid or a salt thereof is 15% to 100% after the composition is applied to a skin for 48 hours.

8. The method of claim 1 , wherein the composition is a cosmetic composition.

9. The method of claim 1 , wherein the composition is a pharmaceutical composition having antiplasmin activity, anticoagulant activity, anti-allergic activity or hyperpigmentation treatment activity.

10. The method of claim 1 , wherein the composition has improved storage stability.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2015
From: LEE, DONG IL; YOON, MIN JI; LEE, PUNG SOK
To: HYUNDAI PHARM CO., LTD.
Reel/Frame 036651/0263 →
Priority Claims (2)
KR 10-2013-0036912 · Apr 4, 2013 · national
KR 10-2014-0036904 · Mar 28, 2014 · national
Continuity (1)
Related Publication 20160058723A1 · Mar 3, 2016